Table 5. Hazard ratios for breast cancer-specific mortality risk in Māori compared with NZ European women with stepwise adjustment for screening status, cancer stage, biological characteristics, comorbidity and treatment factors.
| Characteristics | HR (95% CI) | ||
|---|---|---|---|
| Baseline—Age adjusted | 2.07 (1.64–2.61) | ||
| Model A (Adjusted for socioeconomic deprivation) | 1.98 (1.55–2.54) | ||
| Model B (Model A + Screening status) | 1.82 (1.42–2.32) | ||
| Model C (Model B + Cancer stage at diagnosis) | |||
| Tumour, Lymph nodes & Metastasis | 1.38 (1.06–1.78) | ||
| Model D (Model C + Cancer biological factors) | |||
| ER/PR, Grade, HER-2 & histology | 1.35 (1.05–1.75) | ||
| Model E (Model D + Treatment) | |||
| Use of chemo and endocrine therapy | 1.33 (1.03–1.73) | ||
| Model F (Model E + Patient factors) | |||
| Comorbidity index score | 1.25 (0.97–1.61) | ||